Visceral fungal infections due to petriellidium boydii (allescheria boydii). In vitro drug sensitivity studies

Larry I. Lutwick, John N Galgiani, Rudolph H. Johnson, David A. Stevens

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

Four patients with visceral infections due to the fungus Petriellidium boydii, who were recently hospitalized in our institutions, are described. Three of the patients were compromised hosts; in the fourth patient, infection occurred after trauma. All had received prior steroid and antibiotic therapy. Studies of patients with mycetoma or secondary infection of a pulmonary cavity due to this organism and of patients with visceral infections are reviewed. Because of histologic similarities to Aspergillus species, infections due to P. boydii may have been misdiagnosed in the past if the infecting fungus was not isolated in culture. The fungus has been shown to be resistant in vitro to currently available antifungal agents. Resistance to amphotericin and 5-fluorocytosine is demonstrated in our studies. There are few reports of successful chemotherapy of any manifestation of this infection, and no such reports of visceral disease. We demonstrate in vitro sensitivity of isolates in our cases and in others to miconazole, a new antimicrobial agent; this drug may be indicated for treatment of disease due to P. boydii.

Original languageEnglish (US)
Pages (from-to)632-640
Number of pages9
JournalAmerican Journal of Medicine
Volume61
Issue number5
DOIs
StatePublished - 1976
Externally publishedYes

Fingerprint

Pseudallescheria
Mycoses
Infection
Fungi
Pharmaceutical Preparations
Mycetoma
Miconazole
Flucytosine
Antifungal Agents
Amphotericin B
Aspergillus
Anti-Infective Agents
Diagnostic Errors
Coinfection
Steroids
In Vitro Techniques
Anti-Bacterial Agents
Drug Therapy
Lung
Wounds and Injuries

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Visceral fungal infections due to petriellidium boydii (allescheria boydii). In vitro drug sensitivity studies. / Lutwick, Larry I.; Galgiani, John N; Johnson, Rudolph H.; Stevens, David A.

In: American Journal of Medicine, Vol. 61, No. 5, 1976, p. 632-640.

Research output: Contribution to journalArticle

Lutwick, Larry I. ; Galgiani, John N ; Johnson, Rudolph H. ; Stevens, David A. / Visceral fungal infections due to petriellidium boydii (allescheria boydii). In vitro drug sensitivity studies. In: American Journal of Medicine. 1976 ; Vol. 61, No. 5. pp. 632-640.
@article{2902bfa43ac2490e936078ffd09dcf68,
title = "Visceral fungal infections due to petriellidium boydii (allescheria boydii). In vitro drug sensitivity studies",
abstract = "Four patients with visceral infections due to the fungus Petriellidium boydii, who were recently hospitalized in our institutions, are described. Three of the patients were compromised hosts; in the fourth patient, infection occurred after trauma. All had received prior steroid and antibiotic therapy. Studies of patients with mycetoma or secondary infection of a pulmonary cavity due to this organism and of patients with visceral infections are reviewed. Because of histologic similarities to Aspergillus species, infections due to P. boydii may have been misdiagnosed in the past if the infecting fungus was not isolated in culture. The fungus has been shown to be resistant in vitro to currently available antifungal agents. Resistance to amphotericin and 5-fluorocytosine is demonstrated in our studies. There are few reports of successful chemotherapy of any manifestation of this infection, and no such reports of visceral disease. We demonstrate in vitro sensitivity of isolates in our cases and in others to miconazole, a new antimicrobial agent; this drug may be indicated for treatment of disease due to P. boydii.",
author = "Lutwick, {Larry I.} and Galgiani, {John N} and Johnson, {Rudolph H.} and Stevens, {David A.}",
year = "1976",
doi = "10.1016/0002-9343(76)90141-8",
language = "English (US)",
volume = "61",
pages = "632--640",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Visceral fungal infections due to petriellidium boydii (allescheria boydii). In vitro drug sensitivity studies

AU - Lutwick, Larry I.

AU - Galgiani, John N

AU - Johnson, Rudolph H.

AU - Stevens, David A.

PY - 1976

Y1 - 1976

N2 - Four patients with visceral infections due to the fungus Petriellidium boydii, who were recently hospitalized in our institutions, are described. Three of the patients were compromised hosts; in the fourth patient, infection occurred after trauma. All had received prior steroid and antibiotic therapy. Studies of patients with mycetoma or secondary infection of a pulmonary cavity due to this organism and of patients with visceral infections are reviewed. Because of histologic similarities to Aspergillus species, infections due to P. boydii may have been misdiagnosed in the past if the infecting fungus was not isolated in culture. The fungus has been shown to be resistant in vitro to currently available antifungal agents. Resistance to amphotericin and 5-fluorocytosine is demonstrated in our studies. There are few reports of successful chemotherapy of any manifestation of this infection, and no such reports of visceral disease. We demonstrate in vitro sensitivity of isolates in our cases and in others to miconazole, a new antimicrobial agent; this drug may be indicated for treatment of disease due to P. boydii.

AB - Four patients with visceral infections due to the fungus Petriellidium boydii, who were recently hospitalized in our institutions, are described. Three of the patients were compromised hosts; in the fourth patient, infection occurred after trauma. All had received prior steroid and antibiotic therapy. Studies of patients with mycetoma or secondary infection of a pulmonary cavity due to this organism and of patients with visceral infections are reviewed. Because of histologic similarities to Aspergillus species, infections due to P. boydii may have been misdiagnosed in the past if the infecting fungus was not isolated in culture. The fungus has been shown to be resistant in vitro to currently available antifungal agents. Resistance to amphotericin and 5-fluorocytosine is demonstrated in our studies. There are few reports of successful chemotherapy of any manifestation of this infection, and no such reports of visceral disease. We demonstrate in vitro sensitivity of isolates in our cases and in others to miconazole, a new antimicrobial agent; this drug may be indicated for treatment of disease due to P. boydii.

UR - http://www.scopus.com/inward/record.url?scp=0017137787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017137787&partnerID=8YFLogxK

U2 - 10.1016/0002-9343(76)90141-8

DO - 10.1016/0002-9343(76)90141-8

M3 - Article

C2 - 984066

AN - SCOPUS:0017137787

VL - 61

SP - 632

EP - 640

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 5

ER -